img

Global Trastuzumab Injection Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Trastuzumab Injection Market Insights, Forecast to 2034

Trastuzumab is a targeted cancer drug and is also known by other names such as Herceptin, Herzuma and Ontruzant. It is a treatment for early and advanced breast cancer, advanced stomach cancer and cancer of where the food pipe joins your stomach (gastro oesophageal junction). Trastuzumab injection products are used with other medications or after other medications have been used to treat a certain type of breast cancer that has spread to other parts of the body. Trastuzumab injection products are also used during and after treatment with other medications to decrease the chance that a certain type of breast cancer will return. Trastuzumab injection products are also used with other medications to treat certain types of stomach cancer that have spread to other parts of the body. Trastuzumab is in a class of medications called monoclonal antibodies. It works by stopping the growth of cancer cells.
Global Trastuzumab Injection market is expected to reach to US$ 806 million in 2024, with a positive growth of %, compared with US$ 775 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Trastuzumab Injection industry is evaluated to reach US$ 1098.8 million in 2029. The CAGR will be 5.3% during 2024 to 2029.
Globally, Trastuzumab Injection key manufacturers include Pfizer, Roche, Celltrion, Amgen, Samsung Bioepsis, Mylan, Glenmark, AstraZeneca and Remegen Co., Ltd., etc. Pfizer, Roche, Celltrion are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Trastuzumab Injection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Trastuzumab Injection market and estimated to attract more attentions from industry insiders and investors.
Trastuzumab Injection can be divided into 60 mg, 150 mg, 440 mg and Others, etc. 60 mg is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Trastuzumab Injection is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Trastuzumab Injection industry development. In 2022, global % sales of Trastuzumab Injection went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Trastuzumab Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Trastuzumab Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Roche
Celltrion
Amgen
Samsung Bioepsis
Mylan
Glenmark
AstraZeneca
Remegen Co., Ltd.
Hisun Biopharmaceutical
Shanghai Henlius Biotech
Segment by Type
60 mg
150 mg
440 mg
Others

Segment by Application


Hospitals
Clinics
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Trastuzumab Injection plant distribution, commercial date of Trastuzumab Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Trastuzumab Injection introduction, etc. Trastuzumab Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Trastuzumab Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Trastuzumab Injection Product Introduction
1.2 Market by Type
1.2.1 Global Trastuzumab Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 60 mg
1.2.3 150 mg
1.2.4 440 mg
1.2.5 Others
1.3 Market by Application
1.3.1 Global Trastuzumab Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Trastuzumab Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Trastuzumab Injection Revenue by Region
2.2.1 Global Trastuzumab Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Trastuzumab Injection Revenue by Region (2018-2024)
2.2.3 Global Trastuzumab Injection Revenue by Region (2024-2029)
2.2.4 Global Trastuzumab Injection Revenue Market Share by Region (2018-2029)
2.3 Global Trastuzumab Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Trastuzumab Injection Sales by Region
2.4.1 Global Trastuzumab Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Trastuzumab Injection Sales by Region (2018-2024)
2.4.3 Global Trastuzumab Injection Sales by Region (2024-2029)
2.4.4 Global Trastuzumab Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Trastuzumab Injection Sales by Manufacturers
3.1.1 Global Trastuzumab Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Trastuzumab Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Trastuzumab Injection in 2022
3.2 Global Trastuzumab Injection Revenue by Manufacturers
3.2.1 Global Trastuzumab Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Trastuzumab Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Trastuzumab Injection Revenue in 2022
3.3 Global Key Players of Trastuzumab Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Trastuzumab Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Trastuzumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Trastuzumab Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Trastuzumab Injection, Product Offered and Application
3.8 Global Key Manufacturers of Trastuzumab Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Trastuzumab Injection Sales by Type
4.1.1 Global Trastuzumab Injection Historical Sales by Type (2018-2024)
4.1.2 Global Trastuzumab Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Trastuzumab Injection Sales Market Share by Type (2018-2029)
4.2 Global Trastuzumab Injection Revenue by Type
4.2.1 Global Trastuzumab Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Trastuzumab Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Trastuzumab Injection Revenue Market Share by Type (2018-2029)
4.3 Global Trastuzumab Injection Price by Type
4.3.1 Global Trastuzumab Injection Price by Type (2018-2024)
4.3.2 Global Trastuzumab Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Trastuzumab Injection Sales by Application
5.1.1 Global Trastuzumab Injection Historical Sales by Application (2018-2024)
5.1.2 Global Trastuzumab Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Trastuzumab Injection Sales Market Share by Application (2018-2029)
5.2 Global Trastuzumab Injection Revenue by Application
5.2.1 Global Trastuzumab Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Trastuzumab Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Trastuzumab Injection Revenue Market Share by Application (2018-2029)
5.3 Global Trastuzumab Injection Price by Application
5.3.1 Global Trastuzumab Injection Price by Application (2018-2024)
5.3.2 Global Trastuzumab Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Trastuzumab Injection Market Size by Type
6.1.1 US & Canada Trastuzumab Injection Sales by Type (2018-2029)
6.1.2 US & Canada Trastuzumab Injection Revenue by Type (2018-2029)
6.2 US & Canada Trastuzumab Injection Market Size by Application
6.2.1 US & Canada Trastuzumab Injection Sales by Application (2018-2029)
6.2.2 US & Canada Trastuzumab Injection Revenue by Application (2018-2029)
6.3 US & Canada Trastuzumab Injection Market Size by Country
6.3.1 US & Canada Trastuzumab Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Trastuzumab Injection Sales by Country (2018-2029)
6.3.3 US & Canada Trastuzumab Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Trastuzumab Injection Market Size by Type
7.1.1 Europe Trastuzumab Injection Sales by Type (2018-2029)
7.1.2 Europe Trastuzumab Injection Revenue by Type (2018-2029)
7.2 Europe Trastuzumab Injection Market Size by Application
7.2.1 Europe Trastuzumab Injection Sales by Application (2018-2029)
7.2.2 Europe Trastuzumab Injection Revenue by Application (2018-2029)
7.3 Europe Trastuzumab Injection Market Size by Country
7.3.1 Europe Trastuzumab Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Trastuzumab Injection Sales by Country (2018-2029)
7.3.3 Europe Trastuzumab Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Trastuzumab Injection Market Size
8.1.1 China Trastuzumab Injection Sales (2018-2029)
8.1.2 China Trastuzumab Injection Revenue (2018-2029)
8.2 China Trastuzumab Injection Market Size by Application
8.2.1 China Trastuzumab Injection Sales by Application (2018-2029)
8.2.2 China Trastuzumab Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Trastuzumab Injection Market Size by Type
9.1.1 Asia Trastuzumab Injection Sales by Type (2018-2029)
9.1.2 Asia Trastuzumab Injection Revenue by Type (2018-2029)
9.2 Asia Trastuzumab Injection Market Size by Application
9.2.1 Asia Trastuzumab Injection Sales by Application (2018-2029)
9.2.2 Asia Trastuzumab Injection Revenue by Application (2018-2029)
9.3 Asia Trastuzumab Injection Sales by Region
9.3.1 Asia Trastuzumab Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Trastuzumab Injection Revenue by Region (2018-2029)
9.3.3 Asia Trastuzumab Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Trastuzumab Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Trastuzumab Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Trastuzumab Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Trastuzumab Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Trastuzumab Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Trastuzumab Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Trastuzumab Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Trastuzumab Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Trastuzumab Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Trastuzumab Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Overview
11.2.3 Roche Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Roche Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 Celltrion
11.3.1 Celltrion Company Information
11.3.2 Celltrion Overview
11.3.3 Celltrion Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Celltrion Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celltrion Recent Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Overview
11.4.3 Amgen Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Amgen Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amgen Recent Developments
11.5 Samsung Bioepsis
11.5.1 Samsung Bioepsis Company Information
11.5.2 Samsung Bioepsis Overview
11.5.3 Samsung Bioepsis Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Samsung Bioepsis Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Samsung Bioepsis Recent Developments
11.6 Mylan
11.6.1 Mylan Company Information
11.6.2 Mylan Overview
11.6.3 Mylan Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Mylan Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan Recent Developments
11.7 Glenmark
11.7.1 Glenmark Company Information
11.7.2 Glenmark Overview
11.7.3 Glenmark Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Glenmark Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Glenmark Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 AstraZeneca Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Remegen Co., Ltd.
11.9.1 Remegen Co., Ltd. Company Information
11.9.2 Remegen Co., Ltd. Overview
11.9.3 Remegen Co., Ltd. Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Remegen Co., Ltd. Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Remegen Co., Ltd. Recent Developments
11.10 Hisun Biopharmaceutical
11.10.1 Hisun Biopharmaceutical Company Information
11.10.2 Hisun Biopharmaceutical Overview
11.10.3 Hisun Biopharmaceutical Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Hisun Biopharmaceutical Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hisun Biopharmaceutical Recent Developments
11.11 Shanghai Henlius Biotech
11.11.1 Shanghai Henlius Biotech Company Information
11.11.2 Shanghai Henlius Biotech Overview
11.11.3 Shanghai Henlius Biotech Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Shanghai Henlius Biotech Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai Henlius Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Trastuzumab Injection Industry Chain Analysis
12.2 Trastuzumab Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Trastuzumab Injection Production Mode & Process
12.4 Trastuzumab Injection Sales and Marketing
12.4.1 Trastuzumab Injection Sales Channels
12.4.2 Trastuzumab Injection Distributors
12.5 Trastuzumab Injection Customers
13 Market Dynamics
13.1 Trastuzumab Injection Industry Trends
13.2 Trastuzumab Injection Market Drivers
13.3 Trastuzumab Injection Market Challenges
13.4 Trastuzumab Injection Market Restraints
14 Key Findings in The Global Trastuzumab Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Trastuzumab Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 60 mg
Table 3. Major Manufacturers of 150 mg
Table 4. Major Manufacturers of 440 mg
Table 5. Major Manufacturers of Others
Table 6. Global Trastuzumab Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Trastuzumab Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Trastuzumab Injection Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Trastuzumab Injection Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Trastuzumab Injection Revenue Market Share by Region (2018-2024)
Table 11. Global Trastuzumab Injection Revenue Market Share by Region (2024-2029)
Table 12. Global Trastuzumab Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Trastuzumab Injection Sales by Region (2018-2024) & (K Units)
Table 14. Global Trastuzumab Injection Sales by Region (2024-2029) & (K Units)
Table 15. Global Trastuzumab Injection Sales Market Share by Region (2018-2024)
Table 16. Global Trastuzumab Injection Sales Market Share by Region (2024-2029)
Table 17. Global Trastuzumab Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Trastuzumab Injection Sales Share by Manufacturers (2018-2024)
Table 19. Global Trastuzumab Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Trastuzumab Injection Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Trastuzumab Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Trastuzumab Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Trastuzumab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Trastuzumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trastuzumab Injection as of 2022)
Table 25. Global Key Manufacturers of Trastuzumab Injection, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Trastuzumab Injection, Product Offered and Application
Table 27. Global Key Manufacturers of Trastuzumab Injection, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Trastuzumab Injection Sales by Type (2018-2024) & (K Units)
Table 30. Global Trastuzumab Injection Sales by Type (2024-2029) & (K Units)
Table 31. Global Trastuzumab Injection Sales Share by Type (2018-2024)
Table 32. Global Trastuzumab Injection Sales Share by Type (2024-2029)
Table 33. Global Trastuzumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Trastuzumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Trastuzumab Injection Revenue Share by Type (2018-2024)
Table 36. Global Trastuzumab Injection Revenue Share by Type (2024-2029)
Table 37. Trastuzumab Injection Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Trastuzumab Injection Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Trastuzumab Injection Sales by Application (2018-2024) & (K Units)
Table 40. Global Trastuzumab Injection Sales by Application (2024-2029) & (K Units)
Table 41. Global Trastuzumab Injection Sales Share by Application (2018-2024)
Table 42. Global Trastuzumab Injection Sales Share by Application (2024-2029)
Table 43. Global Trastuzumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Trastuzumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Trastuzumab Injection Revenue Share by Application (2018-2024)
Table 46. Global Trastuzumab Injection Revenue Share by Application (2024-2029)
Table 47. Trastuzumab Injection Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Trastuzumab Injection Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Trastuzumab Injection Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Trastuzumab Injection Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Trastuzumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Trastuzumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Trastuzumab Injection Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Trastuzumab Injection Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Trastuzumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Trastuzumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Trastuzumab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Trastuzumab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Trastuzumab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Trastuzumab Injection Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Trastuzumab Injection Sales by Country (2024-2029) & (K Units)
Table 62. Europe Trastuzumab Injection Sales by Type (2018-2024) & (K Units)
Table 63. Europe Trastuzumab Injection Sales by Type (2024-2029) & (K Units)
Table 64. Europe Trastuzumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Trastuzumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Trastuzumab Injection Sales by Application (2018-2024) & (K Units)
Table 67. Europe Trastuzumab Injection Sales by Application (2024-2029) & (K Units)
Table 68. Europe Trastuzumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Trastuzumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Trastuzumab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Trastuzumab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Trastuzumab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Trastuzumab Injection Sales by Country (2018-2024) & (K Units)
Table 74. Europe Trastuzumab Injection Sales by Country (2024-2029) & (K Units)
Table 75. China Trastuzumab Injection Sales by Type (2018-2024) & (K Units)
Table 76. China Trastuzumab Injection Sales by Type (2024-2029) & (K Units)
Table 77. China Trastuzumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Trastuzumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Trastuzumab Injection Sales by Application (2018-2024) & (K Units)
Table 80. China Trastuzumab Injection Sales by Application (2024-2029) & (K Units)
Table 81. China Trastuzumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Trastuzumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Trastuzumab Injection Sales by Type (2018-2024) & (K Units)
Table 84. Asia Trastuzumab Injection Sales by Type (2024-2029) & (K Units)
Table 85. Asia Trastuzumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Trastuzumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Trastuzumab Injection Sales by Application (2018-2024) & (K Units)
Table 88. Asia Trastuzumab Injection Sales by Application (2024-2029) & (K Units)
Table 89. Asia Trastuzumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Trastuzumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Trastuzumab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Trastuzumab Injection Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Trastuzumab Injection Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Trastuzumab Injection Sales by Region (2018-2024) & (K Units)
Table 95. Asia Trastuzumab Injection Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Trastuzumab Injection Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Trastuzumab Injection Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Trastuzumab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Trastuzumab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Trastuzumab Injection Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Trastuzumab Injection Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Trastuzumab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Trastuzumab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Trastuzumab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Trastuzumab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Trastuzumab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Trastuzumab Injection Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Trastuzumab Injection Sales by Country (2024-2029) & (K Units)
Table 109. Pfizer Company Information
Table 110. Pfizer Description and Major Businesses
Table 111. Pfizer Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Pfizer Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Pfizer Recent Developments
Table 114. Roche Company Information
Table 115. Roche Description and Major Businesses
Table 116. Roche Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Roche Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Roche Recent Developments
Table 119. Celltrion Company Information
Table 120. Celltrion Description and Major Businesses
Table 121. Celltrion Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Celltrion Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Celltrion Recent Developments
Table 124. Amgen Company Information
Table 125. Amgen Description and Major Businesses
Table 126. Amgen Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Amgen Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Amgen Recent Developments
Table 129. Samsung Bioepsis Company Information
Table 130. Samsung Bioepsis Description and Major Businesses
Table 131. Samsung Bioepsis Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Samsung Bioepsis Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Samsung Bioepsis Recent Developments
Table 134. Mylan Company Information
Table 135. Mylan Description and Major Businesses
Table 136. Mylan Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Mylan Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Mylan Recent Developments
Table 139. Glenmark Company Information
Table 140. Glenmark Description and Major Businesses
Table 141. Glenmark Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Glenmark Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Glenmark Recent Developments
Table 144. AstraZeneca Company Information
Table 145. AstraZeneca Description and Major Businesses
Table 146. AstraZeneca Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. AstraZeneca Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. AstraZeneca Recent Developments
Table 149. Remegen Co., Ltd. Company Information
Table 150. Remegen Co., Ltd. Description and Major Businesses
Table 151. Remegen Co., Ltd. Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Remegen Co., Ltd. Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Remegen Co., Ltd. Recent Developments
Table 154. Hisun Biopharmaceutical Company Information
Table 155. Hisun Biopharmaceutical Description and Major Businesses
Table 156. Hisun Biopharmaceutical Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Hisun Biopharmaceutical Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Hisun Biopharmaceutical Recent Developments
Table 159. Shanghai Henlius Biotech Company Information
Table 160. Shanghai Henlius Biotech Description and Major Businesses
Table 161. Shanghai Henlius Biotech Trastuzumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Shanghai Henlius Biotech Trastuzumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Shanghai Henlius Biotech Recent Developments
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Trastuzumab Injection Distributors List
Table 167. Trastuzumab Injection Customers List
Table 168. Trastuzumab Injection Market Trends
Table 169. Trastuzumab Injection Market Drivers
Table 170. Trastuzumab Injection Market Challenges
Table 171. Trastuzumab Injection Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Trastuzumab Injection Product Picture
Figure 2. Global Trastuzumab Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Trastuzumab Injection Market Share by Type in 2022 & 2029
Figure 4. 60 mg Product Picture
Figure 5. 150 mg Product Picture
Figure 6. 440 mg Product Picture
Figure 7. Others Product Picture
Figure 8. Global Trastuzumab Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Trastuzumab Injection Market Share by Application in 2022 & 2029
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Others
Figure 13. Trastuzumab Injection Report Years Considered
Figure 14. Global Trastuzumab Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Trastuzumab Injection Revenue 2018-2029 (US$ Million)
Figure 16. Global Trastuzumab Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Trastuzumab Injection Revenue Market Share by Region (2018-2029)
Figure 18. Global Trastuzumab Injection Sales 2018-2029 ((K Units)
Figure 19. Global Trastuzumab Injection Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Trastuzumab Injection Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Trastuzumab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Trastuzumab Injection Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Trastuzumab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Trastuzumab Injection Sales YoY (2018-2029) & (K Units)
Figure 25. China Trastuzumab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Trastuzumab Injection Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Trastuzumab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Trastuzumab Injection Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Trastuzumab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Trastuzumab Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Trastuzumab Injection in the World: Market Share by Trastuzumab Injection Revenue in 2022
Figure 32. Global Trastuzumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Trastuzumab Injection Sales Market Share by Type (2018-2029)
Figure 34. Global Trastuzumab Injection Revenue Market Share by Type (2018-2029)
Figure 35. Global Trastuzumab Injection Sales Market Share by Application (2018-2029)
Figure 36. Global Trastuzumab Injection Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Trastuzumab Injection Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Trastuzumab Injection Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Trastuzumab Injection Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Trastuzumab Injection Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Trastuzumab Injection Revenue Share by Country (2018-2029)
Figure 42. US & Canada Trastuzumab Injection Sales Share by Country (2018-2029)
Figure 43. U.S. Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Trastuzumab Injection Sales Market Share by Type (2018-2029)
Figure 46. Europe Trastuzumab Injection Revenue Market Share by Type (2018-2029)
Figure 47. Europe Trastuzumab Injection Sales Market Share by Application (2018-2029)
Figure 48. Europe Trastuzumab Injection Revenue Market Share by Application (2018-2029)
Figure 49. Europe Trastuzumab Injection Revenue Share by Country (2018-2029)
Figure 50. Europe Trastuzumab Injection Sales Share by Country (2018-2029)
Figure 51. Germany Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 52. France Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 56. China Trastuzumab Injection Sales Market Share by Type (2018-2029)
Figure 57. China Trastuzumab Injection Revenue Market Share by Type (2018-2029)
Figure 58. China Trastuzumab Injection Sales Market Share by Application (2018-2029)
Figure 59. China Trastuzumab Injection Revenue Market Share by Application (2018-2029)
Figure 60. Asia Trastuzumab Injection Sales Market Share by Type (2018-2029)
Figure 61. Asia Trastuzumab Injection Revenue Market Share by Type (2018-2029)
Figure 62. Asia Trastuzumab Injection Sales Market Share by Application (2018-2029)
Figure 63. Asia Trastuzumab Injection Revenue Market Share by Application (2018-2029)
Figure 64. Asia Trastuzumab Injection Revenue Share by Region (2018-2029)
Figure 65. Asia Trastuzumab Injection Sales Share by Region (2018-2029)
Figure 66. Japan Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 70. India Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Trastuzumab Injection Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Trastuzumab Injection Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Trastuzumab Injection Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Trastuzumab Injection Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Trastuzumab Injection Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Trastuzumab Injection Sales Share by Country (2018-2029)
Figure 77. Brazil Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Trastuzumab Injection Revenue (2018-2029) & (US$ Million)
Figure 82. Trastuzumab Injection Value Chain
Figure 83. Trastuzumab Injection Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries